Correlation Between Inhibrx and Ensysce Biosciences
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Ensysce Biosciences, you can compare the effects of market volatilities on Inhibrx and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Ensysce Biosciences.
Diversification Opportunities for Inhibrx and Ensysce Biosciences
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibrx and Ensysce is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Inhibrx i.e., Inhibrx and Ensysce Biosciences go up and down completely randomly.
Pair Corralation between Inhibrx and Ensysce Biosciences
Given the investment horizon of 90 days Inhibrx is expected to generate 0.61 times more return on investment than Ensysce Biosciences. However, Inhibrx is 1.63 times less risky than Ensysce Biosciences. It trades about -0.02 of its potential returns per unit of risk. Ensysce Biosciences is currently generating about -0.21 per unit of risk. If you would invest 1,355 in Inhibrx on December 1, 2024 and sell it today you would lose (30.00) from holding Inhibrx or give up 2.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Ensysce Biosciences
Performance |
| Timeline |
| Inhibrx |
| Ensysce Biosciences |
Inhibrx and Ensysce Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Ensysce Biosciences
The main advantage of trading using opposite Inhibrx and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Ensysce Biosciences vs. Zura Bio Limited | Ensysce Biosciences vs. Phio Pharmaceuticals Corp | Ensysce Biosciences vs. Sonnet Biotherapeutics Holdings | Ensysce Biosciences vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |